Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-21-000371
Filing Date
2021-02-16
Accepted
2021-02-16 15:12:11
Documents
1
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G/A 145782
  Complete submission text file 0000929638-21-000371.txt   147750
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Subject) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90986 | Film No.: 21636845
SIC: 2834 Pharmaceutical Preparations